What is a good antifungal prescription for fungal infections of the toes and fingers?

Antifungal Treatment for Finger and Toe Nail Infections

Primary Recommendation

For fungal nail infections of fingers and toes, oral terbinafine 250 mg once daily is the first-line treatment: 6 weeks for fingernails and 12 weeks for toenails. 1, 2, 3

---

Treatment Algorithm

Step 1: Confirm Diagnosis Before Treatment

• Always obtain mycological confirmation (direct microscopy and culture) before starting antifungal therapy 4, 2, 5
• Treatment failure most commonly occurs from incorrect clinical diagnosis without laboratory confirmation 2
• This step is critical as it prevents unnecessary treatment and identifies the specific causative organism 5

Step 2: Assess Infection Severity and Type

For Limited Disease (topical therapy candidates):

• Superficial white onychomycosis only 1, 2
• Very early distal infection with <80% nail plate involvement and no lunula involvement 1
• When oral therapy is contraindicated 1, 2

For Most Other Cases (oral therapy required):

• Any infection beyond the criteria above 1, 2
• Multiple nail involvement 6
• Greater than 50% nail plate affected 6

Step 3: Select Appropriate Treatment Based on Organism

For Dermatophyte Infections (most common):

• Terbinafine 250 mg daily: 6 weeks for fingernails, 12 weeks for toenails 1, 2, 3
• This has the highest level of evidence (strength A, level 1+) 2
• Cure rates exceed 80% for both fingernails and toenails 7
• Alternative: Itraconazole 200 mg daily for 12 weeks continuously, or pulse therapy 400 mg daily for 1 week per month (2 pulses for fingernails, 3 pulses for toenails) 1, 2

For Candida Infections (more common in fingernails):

• Itraconazole is preferred over terbinafine for yeast infections 1, 2, 5, 6
• Dosing: 200 mg daily for 12 weeks continuously, or pulse therapy 400 mg daily for 1 week per month 5
• Fingernails are more commonly affected by Candida, especially in occupations with repeated water immersion 5

For Topical-Only Candidates:

• Amorolfine 5% nail lacquer applied once or twice weekly for 6-12 months (approximately 50% efficacy) 1, 2, 5
• Alternative: Ciclopirox 8% lacquer applied daily for up to 24 weeks (fingernails) or 48 weeks (toenails), with 34% mycological cure rate 1, 2
• Alternative: Efinaconazole 10% applied once daily 1, 4

---

Special Populations

Diabetic Patients

• Terbinafine is strongly preferred over itraconazole due to low risk of drug interactions and hypoglycemia 1
• Itraconazole is contraindicated in congestive heart failure, which has increased prevalence in diabetics 1
• Onychomycosis significantly predicts foot ulcer development in diabetes 1

Immunosuppressed Patients (HIV, transplant recipients)

• Terbinafine or fluconazole are preferred over itraconazole due to reduced drug interactions with antiretrovirals and immunosuppressants 1
• Avoid griseofulvin as it is least effective in this population 1

Pediatric Patients

• Pulse itraconazole: 5 mg/kg/day for 1 week per month (2 months for fingernails, 3 months for toenails) 1
• Terbinafine daily: 62.5 mg if <20 kg, 125 mg if 20-40 kg, 250 mg if >40 kg (6 weeks for fingernails, 12 weeks for toenails) 1
• Pediatric cure rates are higher than adults (88-100% in studies) 1

---

Critical Monitoring and Patient Counseling

Before Starting Treatment

• Measure serum transaminases (ALT and AST) before initiating terbinafine 3

During Treatment

• Warn patients about liver toxicity signs: persistent nausea, anorexia, fatigue, vomiting, right upper abdominal pain, jaundice, dark urine, or pale stools 3
• Monitor for taste/smell disturbances: These may be prolonged or permanent; discontinue if they occur 3
• Watch for serious skin reactions: hives, mouth sores, blistering, peeling skin, facial swelling, difficulty swallowing or breathing 3
• Advise sun protection: Photosensitivity reactions can occur; minimize natural and artificial UV exposure 3

Setting Expectations

• Complete cure takes months after treatment completion due to slow nail growth 4, 3
• Mycological cure rates are typically 30% better than clinical cure rates 4
• Even with optimal treatment, failure rates of 20-30% are common 2
• Recurrence rates are high (40-70%), requiring preventive strategies 2

---

Common Pitfalls to Avoid

1. Starting treatment without mycological confirmation is the most common cause of treatment failure 2
2. Underdosing or insufficient treatment duration leads to poor outcomes 1, 3
3. Using topical therapy for extensive disease results in predictable failure 1, 2
4. Failing to identify Candida infections in fingernails, which require azole therapy rather than terbinafine 5, 6
5. Not considering drug interactions in patients on multiple medications, particularly with itraconazole 1, 3